Advertisement
Articles
Subscribe to Bioscience Technology Articles

The Lead

Cloning Pioneer Proposes Global Network of iPS Cell Banks

November 25, 2014 | by Cynthia Fox, Science Writer | Comments

Ian Wilmut, father of the cloned Dolly the Sheep, is now proposing to father a global Induced Pluripotent Stem (iPS) cell handbook— to go with a proposed new global network of IPS cell haplobanks.               

TOPICS:
View Sample

FREE Email Newsletter Bioscience Technology Daily

New Studies Show Anxiety, Depression, Guilt Harm the Brain

November 26, 2014 8:30 am | by Bioscience Technology Staff | Comments

Two studies in recent weeks have found that anxiety, depression and guilt can physically change and damage the brain from preschool through adulthood.                            

TOPICS:

Streamline Your Sample Preparation

November 21, 2014 10:15 am | by Joanne Ratcliff, PhD, Communications Project Manager, Laboratory Weighing Group, Mettler-Toledo AG | Comments

Why do labs have such difficultly getting a handle on the source of OOS results? Part of the answer can be attributed to the still-common practice of manual volumetric sample preparation. Now, there is a new technique: gravimetric sample preparation.

TOPICS:

Mental Health Problems Increase Cardiovascular Disease Risk

November 19, 2014 2:18 pm | by Cynthia Fox, Science Writer | Comments

People with mental health problems are “significantly” more likely to have stroke or heart disease, according to a study unveiled at a recent Canadian Cardiovascular Congress.                    

TOPICS:
Advertisement

Going Purple: 5 Cutting-edge Breakthroughs in Alzheimer’s Research

November 17, 2014 11:48 am | by Christina Jakubowski, Managing Editor | Comments

November is already halfway over— which means we’re also halfway through National Alzheimer's Disease Awareness Month, which celebrates and raises awareness for the nearly 5.4 million people who have this condition. Read more...

TOPICS:

The Odd Ouster of Sanofi’s Former CEO

November 13, 2014 9:29 am | by Ryan Bushey, Associate Editor | Comments

Chris Viehbacher, the high-flying pharma executive, had his career with Sanofi derailed for a variety of surprising factors. Here's a look at the odd ouster of the former CEO.                    

TOPICS:

Revolutionary New Microscope: Real-time Movies of Molecules

November 12, 2014 8:30 am | by Cynthia Fox, Science Writer | Comments

A new microscope, using a new form of the much-hailed light sheet-based fluorescence microscopy (LSFM), makes visible— via stunning movies— countless biological processes once deemed utterly invisible: sub-cellular activity.       

TOPICS:

Ebola Health Lessons: A Wake-up Call

November 11, 2014 8:30 am | by Stephanie Guzowski, Editor, Drug Discovery & Development | Comments

After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned.        

TOPICS:

Fighting HIV with Stem Cells and Cutting-edge Genetics

November 10, 2014 2:34 pm | by Cynthia Fox, Science Writer | Comments

“Berlin Patient” Timothy Brown was cured of HIV after he received stem cells from a naturally immune patient. His story inspired two companies to try and recreate that natural immunity in HIV patients using stem cells and cutting-edge gene-editing. Now Harvard has joined the race.

TOPICS:
Advertisement

Ebola and Marburg are Millions of Years Old, Not Thousands

November 6, 2014 2:19 pm | by Cynthia Fox, Science Writer | Comments

Ebola and Marburg are 16 to 23 million years old, not thousands of years old as once thought, according to a new study. The research also indicates that while Ebola and Marburg diverged from each other millions of years ago.    

TOPICS:

Google’s Next Business Venture: The Human Body

November 5, 2014 8:30 am | by Ryan Bushey, Associate Editor | Comments

Through a new, semi-secretive extension of the company, Google is working on a slew of ambitious projects that could drastically revolutionize healthcare as we know it.                    

TOPICS:

Special Report: Imagine Science Film Festival

October 31, 2014 3:00 pm | by Cynthia Fox, Science Writer | Comments

One of the enduring images of this year’s Imagine Science Film Festival, held in New York on Oct. 17 to 24, was that of a girl in a black abeyya lugging a giant white telescope up a hill, escaping her cruel Iranian life to lose herself in the stars in the film “Sepideh.” 

TOPICS:

World-First Embryonic Stem Cell Trial for the Heart

October 30, 2014 9:37 am | by Cynthia Fox, Science Writer | Comments

The first embryonic stem (ES) cell trial for severe heart failure is launching now in Paris. The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates.       

TOPICS:

Patient-relevant Preclinical Models Using Image-guided Small Animal Irradiation

October 28, 2014 11:33 am | by Dr. Rajendra Kumari, Chief Scientific Officer, PRECOS Ltd., a Crown Bioscience Company | Comments

Radiotherapy is a primary, adjuvant or neoadjuvant treatment for a number of different cancers, such as glioblastoma, breast, lung and prostate. Image-guided radiation therapy (IGRT) is used to reduce the amount of radiation delivered to the normal tissue surrounding the targeted tumor. However, in the preclinical setting, the use of IGRT is less common.

TOPICS:

Imaging and Analysis with Flying Colors: Part One

October 22, 2014 8:30 am | by Mark Clymer, Director of Marketing, Datacolor Inc. | Comments

Researchers are facing increasing demands from colleagues, peers and publishers for process documentation including adequate controls, and for extensive documentation of experimental parameters. Without such consideration, there would be little chance to repeat, or even validate, findings.

TOPICS:

Seeing is Believing: Reproducible Proteomic Studies

October 21, 2014 1:03 pm | by Anton Posch, Senior Scientist, Bio-Rad Laboratories | Comments

For scientists, the field of proteomics has always been a double-edged sword. On one hand, technologies such as 2-dimensional gel electrophoresis (2-DE) capture a vastly improved picture of protein expression in action. But when others try to reproduce the experiment? The findings can suddenly appear blurry.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading